Lobe Sciences Ltd (LOBE.CX)
0.02
0.00 (0.00%)
CAD |
CNSX |
Nov 22, 15:54
Lobe Sciences Net Income (Quarterly): -0.4268M for May 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2024 | -0.4268M |
| February 29, 2024 | -0.5955M |
| November 30, 2023 | -0.568M |
| August 31, 2023 | -1.376M |
| May 31, 2023 | -0.3121M |
| February 28, 2023 | -1.002M |
| November 30, 2022 | -2.017M |
| August 31, 2022 | -2.604M |
| May 31, 2022 | -1.962M |
| February 28, 2022 | -3.113M |
| November 30, 2021 | -4.574M |
| August 31, 2021 | -17.04M |
| May 31, 2021 | 11.20M |
| February 28, 2021 | -2.575M |
| November 30, 2020 | -1.245M |
| August 31, 2020 | -1.436M |
| May 31, 2020 | -0.318M |
| February 29, 2020 | -0.9992M |
| November 30, 2019 | -0.6833M |
| August 31, 2019 | -0.943M |
| May 31, 2019 | 1.065M |
| March 31, 2019 | -0.052M |
| December 31, 2018 | -0.1118M |
| September 30, 2018 | -0.0154M |
| June 30, 2018 | -0.0085M |
| Date | Value |
|---|---|
| March 31, 2018 | -0.0127M |
| December 31, 2017 | -0.0195M |
| September 30, 2017 | -0.0088M |
| June 30, 2017 | -0.0146M |
| March 31, 2017 | -0.009M |
| December 31, 2016 | -0.0237M |
| September 30, 2016 | -0.0142M |
| June 30, 2016 | -0.0074M |
| March 31, 2016 | -0.0106M |
| December 31, 2015 | -0.1243M |
| September 30, 2015 | -0.0143M |
| June 30, 2015 | -0.013M |
| March 31, 2015 | -0.0193M |
| December 31, 2014 | -0.0243M |
| September 30, 2014 | -0.0297M |
| June 30, 2014 | -0.0288M |
| March 31, 2014 | -0.0237M |
| December 31, 2013 | -0.0344M |
| September 30, 2013 | -0.0269M |
| June 30, 2013 | -0.0353M |
| March 31, 2013 | -0.0374M |
| December 31, 2012 | -0.0129M |
| September 30, 2012 | -0.0483M |
| June 30, 2012 | -0.0243M |
| March 31, 2012 | -0.0076M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-17.04M
Minimum
Aug 2021
11.20M
Maximum
May 2021
-1.666M
Average
-1.245M
Median
Nov 2020
Net Income (Quarterly) Benchmarks
| Biocure Technology Inc | -0.0201M |
| Core One Labs Inc | -0.8407M |
| Restart Life Sciences Corp | -0.0906M |
| Nanosphere Health Sciences Inc | -0.0835M |
| Algernon Pharmaceuticals Inc | -1.88M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.6236M |
| EPS Diluted (Quarterly) | -0.0027 |
| Enterprise Value | 4.758M |
| Earnings Yield | -200.4% |
| Normalized Earnings Yield | -199.70 |